You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR BREVIBLOC

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for BREVIBLOC

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01114971 ↗	Labetalol and Esmolol: Vital Signs and Post Operative Pain Management	Completed	Cedars-Sinai Medical Center	Phase 4	2009-09-03	This study proposes to investigate the effects of labetalol or esmolol on managing the vital signs (like blood pressure and heart rate) during surgery, on pain management, and on the later recovery after surgery. It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient surgery.
NCT01179113 ↗	Esmolol Infusion During Laminectomy: Effect on Quality of Recovery	Terminated	Cedars-Sinai Medical Center	Phase 4	2011-06-01	The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly administered during surgery to help control blood pressure and heart rate, on postoperative pain levels and requirements for pain medication.
NCT01208402 ↗	Esmolol for Treatment of Perioperative Tachycardia	Terminated	Baxter Healthcare Corporation	Phase 3	2010-09-01	The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for BREVIBLOC

Condition Name

Chart
Table

Condition Name for BREVIBLOC
Intervention	Trials
Septic Shock	3
Overdose of Beta-adrenergic Blocking Drug	1
Healthy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for BREVIBLOC
Intervention	Trials
Shock, Septic	3
Shock	3
Tachycardia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for BREVIBLOC

Trials by Country

Map
Table

Trials by Country for BREVIBLOC
Location	Trials
United States	8
Brazil	6
Turkey	3
Czech Republic	1
Denmark	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for BREVIBLOC
Location	Trials
Utah	2
California	2
Maryland	1
Michigan	1
Ohio	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for BREVIBLOC

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for BREVIBLOC
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	1
Phase 2	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for BREVIBLOC
Clinical Trial Phase	Trials
Completed	7
Unknown status	3
Withdrawn	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BREVIBLOC

Sponsor Name

Chart
Table

Sponsor Name for BREVIBLOC
Sponsor	Trials
Diskapi Teaching and Research Hospital	2
Cedars-Sinai Medical Center	2
Baxter Healthcare Corporation	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for BREVIBLOC
Sponsor	Trials
Other	19
Industry	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.